Signaling pathways
-
BA2262 LP-935509Summary: LP-935509 is an orally potent, selective, ATP-competitive, and blood-brain barrier-crossing inhibitor of junctional protein-2-related kinase 1. - BA2266 EnoxaparinSummary: Enoxaparin (PK10169) is a low molecular heparin (LMWH) derivative.
- BA2271 Vps34-IN-2Summary: Vps34-IN-2 is a novel, potent and selective inhibitor.
- BA2273 QuipazineSummary: Quipazine is an agonist.
- BA2276 ONO-5334Summary: ONO-5334 is a potent, selective and orally active tissue proteinase K inhibitor.
- BA2278 rel-ZotatifinSummary: re-Zotatifin is a racemic isomer of Zotatifin and is less active than Zotatifin as an eIF4A inhibitor.
- BA2301 SSAA09E1Summary: SSAA09E1 is a histone L blocker (5.33 μM).
- BA2302 KW-8232Summary: KW-8232 is an orally active anti-osteoporotic agent.
- BA2307 BurfiralimabSummary: Burfiralimab (hzVSF-v13) is a monoclonal antibody directed against waveform proteins expressed on the surface of virus-infected cells with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation.
- BA2311 4E2RCatSummary: 4E2RCat is an inhibitor of the interaction.